Finger-Stick Whole Blood HIV-1/-2 Home-Use Tests Are More Sensitive than Oral Fluid-Based In-Home HIV Tests

Background Several countries have recently recommended the expansion of anti-human immunodeficiency virus (HIV) antibody testing, including self-testing with rapid tests using oral fluid (OF). Several tests have been proposed for at-home use, but their diagnostic accuracy has not been fully evaluated. Objective To evaluate the performance of 5 rapid diagnostic tests for the detection of anti-HIV-1/2 antibodies, with 4 testing OF and 1 testing whole blood. Methods Prospective multi-center study in France. HIV-infected adults and HIV-uninfected controls were systematically screened with 5 at-home HIV tests using either OF or finger-stick blood (FSB) specimens. Four OF tests (OraQuick Advance Rapid HIV-1/2, Chembio DPP HIV 1/2 Assay, test A, and test B) and one FSB test (Chembio Sure Check HIV1/2 Assay) were performed by trained health workers and compared with laboratory tests. Results In total, 179 HIV-infected patients (M/F sex ratio: 1.3) and 60 controls were included. Among the HIV-infected patients, 67.6% had an undetectable HIV viral load in their plasma due to antiretroviral therapy. Overall, the sensitivities of the OF tests were 87.2%, 88.3%, 58.9%, and 28% (for OraQuick, DPP, test A, and test B, respectively) compared with 100% for the FSB test Sure Check (p<0.0001 for all comparisons). The OraQuick and DPP OF tests' sensitivities were significantly lower than that of the FSB-based Sure Check (p<0.05). The sensitivities of the OF tests increased among the patients with a detectable HIV viral load (>50 copies/mL), reaching 94.8%, 96.5%, 90%, and 53.1% (for OraQuick, DPP, test A, and test B, respectively). The specificities of the four OF tests were 98.3%, 100%, 100%, and 87.5%, respectively, compared with 100% for the FSB test. Conclusion An evaluation of candidates for HIV self-testing revealed unexpected differences in performance of the rapid tests: the FSB test showed a far greater reliability than OF tests.

[1]  R. Walensky,et al.  Acceptability of Fingerstick Versus Oral Fluid Rapid HIV Testing: Results From the Universal Screening for HIV Infection in the Emergency Room (USHER Phase II) Randomized Controlled Trial , 2012, Journal of acquired immune deficiency syndromes.

[2]  G. Barrio,et al.  Are Participants in a Street-Based HIV Testing Program Able to Perform Their Own Rapid Test and Interpret the Results? , 2012, PloS one.

[3]  V. Lee,et al.  Accuracy and User-Acceptability of HIV Self-Testing Using an Oral Fluid-Based HIV Rapid Test , 2012, PloS one.

[4]  Helen Ayles,et al.  Field comparison of OraQuick® ADVANCE Rapid HIV-1/2 antibody test and two blood-based rapid HIV antibody tests in Zambia , 2012, BMC Infectious Diseases.

[5]  Y. Le Strat,et al.  Prevalence and characteristics of individuals with undiagnosed HIV infection in France: evidence from a survey on hepatitis B and C seroprevalence. , 2012, Journal of acquired immune deficiency syndromes.

[6]  B. Spire,et al.  Access to and use of unauthorised online HIV self-tests by internet-using French-speaking men who have sex with men , 2012, Sexually Transmitted Infections.

[7]  Patricia Agreda,et al.  Will patients "opt in" to perform their own rapid HIV test in the emergency department? , 2011, Annals of emergency medicine.

[8]  B. Branson,et al.  Evaluation of the performance characteristics of 6 rapid HIV antibody tests. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  C. Delaugerre,et al.  Sensitivity of Five Rapid HIV Tests on Oral Fluid or Finger-Stick Whole Blood: A Real-Time Comparison in a Healthcare Setting , 2010, PloS one.

[10]  Jeffrey N. Martin,et al.  Late-Disease Stage at Presentation to an HIV Clinic in the Era of Free Antiretroviral Therapy in Sub-Saharan Africa , 2009, Journal of acquired immune deficiency syndromes.

[11]  James Mudzori,et al.  Field evaluation of diagnostic accuracy of an oral fluid rapid test for HIV, tested at point-of-service sites in rural Zimbabwe. , 2009, AIDS patient care and STDs.

[12]  Á. Holguín,et al.  Performance of OraQuick Advance Rapid HIV-1/2 Antibody Test for detection of antibodies in oral fluid and serum/plasma in HIV-1+ subjects carrying different HIV-1 subtypes and recombinant variants. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[13]  D. Wight,et al.  Feasibility and acceptability of offering rapid HIV tests to patients registering with primary care in London (UK): a pilot study , 2009, Sexually Transmitted Infections.

[14]  J. Brun,et al.  [Benefits of a levonorgestrel-releasing intrauterine device]. , 2009, Journal de gynecologie, obstetrique et biologie de la reproduction.

[15]  A. Dubey,et al.  Decentralization of HIV care in St. Petersburg Russia. , 2009 .

[16]  C. Delpierre,et al.  High-Risk groups for late diagnosis of HIV infection: a need for rethinking testing policy in the general population. , 2006, AIDS patient care and STDs.

[17]  P. Sullivan,et al.  Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing , 2006, AIDS.

[18]  J. Sterne,et al.  Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries , 2006, The Lancet.

[19]  Robert J. O'Connell,et al.  Performance of the OraQuick Rapid Antibody Test for Diagnosis of Human Immunodeficiency Virus Type 1 Infection in Patients with Various Levels of Exposure to Highly Active Antiretroviral Therapy , 2003, Journal of Clinical Microbiology.

[20]  T. Granade,et al.  Oral fluid as a specimen for detection and confirmation of antibodies to human immunodeficiency virus type 1 , 1995, Clinical and diagnostic laboratory immunology.

[21]  N. Constantine,et al.  Serological diagnosis of HIV infection using oral fluid samples. , 1994, Bulletin of the World Health Organization.